Patents Represented by Attorney Terrence J. Bogie

Find this attorney in the Justia Lawyer Directory

  • Cyclic derivatives as modulators of chemokine receptor activity
    Patent number: 7572813
    Abstract: The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: August 11, 2009
    Assignee: Bristol-Myers Squibb Company
    Inventor: Robert Cherney
  • Cycloalkyl inhibitors of potassium channel function
    Patent number: 7202253
    Abstract: Novel cycloalkyl compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultra-rapidly activating delayed rectifier K+ current IKur), methods of using such compounds in the prevention and treatment of arrhythmia and IKur-associated conditions, and pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: November 24, 2004
    Date of Patent: April 10, 2007
    Assignees: Bristol-Myers Squibb Company, Icagen, Inc.
    Inventors: John Lloyd, Yoon T. Jeon, Heather Finlay, Lin Yan, Michael F. Gross, Serge Beaudoin